Showing results (401-410 of 474) with videos related to
Sort By:
Pageof 48
Plos One|September 22, 2020
Malignancy in U.S. Air Force fighter pilots and other officers, 1986-2017: A retrospective cohort studyAnthony S Robbins, Sonal R Pathak, Bryant J Webber, et al.CA: a Cancer Journal for Clinicians|June 4, 2014
Cancer treatment and survivorship statistics, 2014Carol E DeSantis, Chun Chieh Lin, Angela B Mariotto, et al.Infection and Immunity|July 5, 2017
S-Nitrosoglutathione Reductase Deficiency Confers Improved Survival and Neurological Outcome in Experimental Cerebral MalariaRobyn E Elphinstone, Rickvinder Besla, Eric A Shikatani, et al.Journal of Chemical Ecology|February 28, 2009
Sex pheromone of the scarab beetle Phyllophaga (Phytalus) georgiana (horn)Paul S Robbins, Satoshi Nojima, Sridhar Polavarapu, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 11, 2014
Improvements in HIV care engagement and viral load suppression following enrollment in a comprehensive HIV care coordination programMary K Irvine, Stephanie A Chamberlin, Rebekkah S Robbins, et al.The Journal of Cell Biology|July 1, 1998
Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: an autocrine mechanism contributing to angiogenesisG Seghezzi, S Patel, C J Ren, et al.Spine|August 15, 1996
Semirigid instrumentation in the management of lumbar spinal conditions combined with circumferential fusion. A multicenter studyS D Gertzbein, R Betz, D Clements, et al.Plos One|September 27, 2014
Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1Lilia Maneva-Radicheva, Christina Amatya, Camille Parker, et al.Plos One|August 8, 2014
Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitusTadeusz Kolodka, Matthew L Charles, Arvind Raghavan, et al.Headache|September 27, 2020
A Randomized, Double-Dummy, Emergency Department-Based Study of Greater Occipital Nerve Block With Bupivacaine vs Intravenous Metoclopramide for Treatment of MigraineBenjamin W Friedman, Eddie Irizarry, Andrew Williams, et al.Pageof 48